Avanos Medical, Inc.AVNSNYSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank29
3Y CAGR-2.9%
5Y CAGR+0.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-2.9%/yr
vs +0.7%/yr prior
5Y CAGR
+0.8%/yr
Recent deceleration
Acceleration
-3.6pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$296.00M-6.1%
2024$315.10M+9.6%
2023$287.50M-11.0%
2022$323.10M+23.9%
2021$260.80M-8.4%
2020$284.80M-23.0%
2019$369.90M+17.7%
2018$314.20M-0.2%
2017$314.70M-4.1%
2016$328.20M-